These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 29556285)
1. Overexpression of long non-coding RNA CRNDE facilitates epithelial-mesenchymal transition and correlates with poor prognosis in intrahepatic cholangiocarcinoma. Xia XL; Xue D; Xiang TH; Xu HY; Song DK; Cheng PG; Wang JQ Oncol Lett; 2018 Apr; 15(4):4105-4112. PubMed ID: 29556285 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of long non‑coding RNA CCAT2 indicates a poor prognosis and promotes proliferation and metastasis in intrahepatic cholangiocarcinoma. Bai JG; Tang RF; Shang JF; Qi S; Yu GD; Sun C Mol Med Rep; 2018 Apr; 17(4):5328-5335. PubMed ID: 29393466 [TBL] [Abstract][Full Text] [Related]
3. Long non‑coding RNA ZEB1‑AS1 predicts a poor prognosis and promotes cancer progression through the miR‑200a/ZEB1 signaling pathway in intrahepatic cholangiocarcinoma. Jiao M; Ning S; Chen J; Chen L; Jiao M; Cui Z; Guo L; Mu W; Yang H Int J Oncol; 2020 Jun; 56(6):1455-1467. PubMed ID: 32236578 [TBL] [Abstract][Full Text] [Related]
4. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway. Zhao S; Wang J; Qin C J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741 [TBL] [Abstract][Full Text] [Related]
5. LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition. Li Z; Tang Y; Xing W; Dong W; Wang Z Exp Mol Pathol; 2018 Feb; 104(1):19-25. PubMed ID: 29246789 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA CRNDE regulates cell proliferation, migration, invasion, epithelial-mesenchymal transition and apoptosis in oral squamous cell carcinoma. Dai J; Mu JW; Mu H Oncol Lett; 2019 Mar; 17(3):3330-3340. PubMed ID: 30867767 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p. Jing H; Xia H; Qian M; Lv X Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121 [TBL] [Abstract][Full Text] [Related]
9. LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma. Ding C; Han F; Xiang H; Xia X; Wang Y; Dou M; Zheng J; Li Y; Xue W; Ding X; Tian P J Cell Biochem; 2018 Dec; 119(12):10406-10414. PubMed ID: 30129055 [TBL] [Abstract][Full Text] [Related]
10. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma. Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932 [TBL] [Abstract][Full Text] [Related]
11. Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma. Zhang TJ; Xue D; Zhang CD; Zhang ZD; Liu QR; Wang JQ World J Gastroenterol; 2017 Apr; 23(13):2318-2329. PubMed ID: 28428711 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CRNDE may be associated with poor prognosis by promoting proliferation and inhibiting apoptosis of cervical cancer cells through targeting PI3K/AKT. Yang HY; Huang CP; Cao MM; Wang YF; Liu Y Neoplasma; 2018 Nov; 65(6):872-880. PubMed ID: 30334449 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA CRNDE is a novel tumor promoter by modulating PI3K/AKT signal pathways in human gastric cancer. Du DX; Lian DB; Amin BH; Yan W Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5392-5398. PubMed ID: 29243780 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Long Noncoding RNA CRNDE as a Novel Biomarker in Solid Cancers: An Updated Systematic Review and Meta-Analysis. Zhou Y; Wang R; Xu T; Xie P; Zhang Y; Zhang A; Wang X; Yang C; Yang H; Zhu S J Cancer; 2019; 10(11):2386-2396. PubMed ID: 31258743 [No Abstract] [Full Text] [Related]
15. Long noncoding RNA CRNDE activates Wnt/β-catenin signaling pathway through acting as a molecular sponge of microRNA-136 in human breast cancer. Huan J; Xing L; Lin Q; Xui H; Qin X Am J Transl Res; 2017; 9(4):1977-1989. PubMed ID: 28469804 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of lncRNA-NEF indicates poor prognosis in intrahepatic cholangiocarcinoma. Liang Z; Zhu B; Meng D; Shen X; Li X; Wang Z; Li L Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015363 [TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma. Xu YF; Yang XQ; Lu XF; Guo S; Liu Y; Iqbal M; Ning SL; Yang H; Suo N; Chen YX Biochem Biophys Res Commun; 2014 Mar; 446(1):54-60. PubMed ID: 24565842 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition. Xu Y; Yao Y; Qin W; Zhong X; Jiang X; Cui Y Biomed Pharmacother; 2018 Mar; 99():121-127. PubMed ID: 29329034 [TBL] [Abstract][Full Text] [Related]
19. Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma. Yang SZ; Wang AQ; Du J; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG World J Gastroenterol; 2016 Jul; 22(25):5814-21. PubMed ID: 27433094 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA BRAF-regulated lncRNA 1 promotes lymph node invasion, metastasis and proliferation, and predicts poor prognosis in breast cancer. Jiang J; Shi SH; Li XJ; Sun L; Ge QD; Li C; Zhang W Oncol Lett; 2018 Jun; 15(6):9543-9552. PubMed ID: 29805676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]